Structural brain changes and cognition in relation to markers of vascular dysfunction

dc.contributor.author
Miralbell Blanch, Júlia
dc.contributor.author
Soriano Raya, Juan José
dc.contributor.author
Spulber, Gabriela
dc.contributor.author
López Cancio, Elena
dc.contributor.author
Arenillas, Juan Francisco
dc.contributor.author
Bargalló Alabart, Núria
dc.contributor.author
Galán, Amparo
dc.contributor.author
Barrios Cerrejón, M. Teresa
dc.contributor.author
Cáceres, Cynthia
dc.contributor.author
Alzamora, María Teresa
dc.contributor.author
Pera, Guillem
dc.contributor.author
Kivipelto, Miia
dc.contributor.author
Wahlund, Lars-Olof
dc.contributor.author
Dávalos, Antoni
dc.contributor.author
Mataró Serrat, Maria
dc.date.accessioned
2026-01-30T09:54:46Z
dc.date.available
2026-01-30T09:54:46Z
dc.date.issued
2026-01-29T13:54:46Z
dc.date.issued
2026-01-29T13:54:46Z
dc.date.issued
2012-05
dc.date.issued
2026-01-29T13:54:46Z
dc.identifier
0197-4580
dc.identifier
https://hdl.handle.net/2445/226410
dc.identifier
600072
dc.identifier.uri
http://hdl.handle.net/2445/226410
dc.description.abstract
The aim was to investigate the relationship between blood markers of vascular dysfunction with brain microstructural changes and cognition. Eighty-six participants from the Barcelona-Asymptomatic Intracranial Atherosclerosis (AsIA) neuropsychology study were included. Subjects were 50–65 years old, free from dementia and without history of vascular disease. We assessed correlations of blood levels of inflammatory biomarkers (C-reactive protein [CRP] and resistin) and fibrinolysis inhibitors (plasminogen activator inhibitor-1 [PAI-1] and A-lipoprotein (Lp (a)) with fractional anisotropy (FA) measurements of diffusion tensor images (DTI), regional gray matter (GM) volumes and performance in several cognitive domains. Increasing levels of C-reactive protein and PAI-1 levels were associated with white matter (WM) integrity loss in corticosubcortical pathways and association fibers of frontal and temporal lobes, independently of age, sex and vascular risk factors. PAI-1 was also related to lower speed and visuomotor/coordination. None of the biomarkers were related to gray matter volume changes. Our findings suggest that inflammation and dysregulation of the fibrynolitic system may be involved in the pathological mechanisms underlying the WM damage seen in cerebrovascular disease and subsequent cognitive impairment.
dc.format
17 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
Elsevier B.V.
dc.relation
Versió postprint del document publicat a: https://doi.org/10.1016/j.neurobiolaging.2011.09.020
dc.relation
Neurobiology of Aging, 2012, vol. 33, num.5, p. 1003.e9-1003.e17
dc.relation
https://doi.org/10.1016/j.neurobiolaging.2011.09.020
dc.rights
(c) Elsevier B.V., 2012
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Malalties cerebrovasculars
dc.subject
Cervell
dc.subject
Cerebrovascular disease
dc.subject
Brain
dc.title
Structural brain changes and cognition in relation to markers of vascular dysfunction
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.